# Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults

> **NCT06798831** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **BioNet-Asia Co., Ltd.** · enrollment: 2399 (actual)

## Conditions studied

- Pertussis Vaccine

## Interventions

- **BIOLOGICAL:** Pertussis containing vaccine

## Key facts

- **NCT ID:** NCT06798831
- **Lead sponsor:** BioNet-Asia Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-08
- **Primary completion:** 2025-04-04
- **Final completion:** 2025-10-31
- **Target enrollment:** 2399 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798831, "Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06798831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*